Gaël Dos Santos

Universidade Federal de Campina Grande — Brazil

Medicine · Health Sciences

19h-index1.3kcitations64works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(42), Respiratory viral infections research(29), Vaccine Coverage and Hesitancy(10), COVID-19 epidemiological studies(7), Viral gastroenteritis research and epidemiology(5)

Publications64 total

MANEJO DA TROMBOCITOPENIA IMUNE PRIMÁRIA NA PEDIATRIA NA ERA DOS AGONISTAS DOS RECEPTORES DA TROMBOPOIETINA
Hematology Transfusion and Cell Therapy·2025Open Access
HEMOFILIA B SECUNDÁRIA A LÚPUS ERITEMATOSO SISTÊMICO PRÉ-CLÍNICO: UM RELATO DE CASO
Hematology Transfusion and Cell Therapy·2025Open Access
A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and <i>Haemophilus influenzae</i> type b invasive infections (DTaP-IPV/Hib) in South Korean infants
Human Vaccines & Immunotherapeutics·2024· 1 citedOpen Access
Inconsistent Increase in Age at Respiratory Syncytial Virus Hospitalization of Children Aged &amp;lt;2 Years During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Retrospective Multicenter Study in 4 European Countries
The Journal of Infectious Diseases·2024· 5 citedOpen Access
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older
Drug Safety·2024· 2 citedOpen Access
Incidence of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 Pandemic
Open Forum Infectious Diseases·2023· 3 citedOpen Access
Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study
The Journal of Infectious Diseases·2023· 16 citedOpen Access
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study
The Journal of Infectious Diseases·2023· 9 citedOpen Access
Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study
The Journal of Infectious Diseases·2023· 7 citedOpen Access
Burden of Respiratory Syncytial Virus–Associated Acute Respiratory Infections During Pregnancy
The Journal of Infectious Diseases·2023· 20 citedOpen Access
Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A Systematic Review
The Journal of Infectious Diseases·2023· 15 citedOpen Access
Underreporting and Misclassification of Respiratory Syncytial Virus–Coded Hospitalization Among Adults in Denmark Between 2015–2016 and 2017–2018
The Journal of Infectious Diseases·2023· 22 citedOpen Access
Respiratory Syncytial Virus European Laboratory Network 2022 Survey: Need for Harmonization and Enhanced Molecular Surveillance
The Journal of Infectious Diseases·2023· 11 citedOpen Access
Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis
The Journal of Infectious Diseases·2023· 12 citedOpen Access
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote monitoring
Influenza and Other Respiratory Viruses·2023· 9 citedOpen Access
Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project
Influenza and Other Respiratory Viruses·2022· 13 citedOpen Access
Author response for "Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project"
2022
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative
Expert Review of Vaccines·2022· 8 citedOpen Access
Contributing to Safety Evaluations in Studies in Adolescent and Young Adult Pregnant Women and Their Infants: An Observational Study to Assess Pregnancy Outcomes and Events, and Neonatal and Infant Events (Preprint)
2022Open Access
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany
Human Vaccines & Immunotherapeutics·2022· 8 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Vivek Shinde(14), François Haguinet(12), Harish Nair(12), Anne Teirlinck(12), Rolf Kramer(10), Melissa K. Andrew(9), Todd F. Hatchette(9), Janet E. McElhaney(9), May ElSherif(9), Jason J. LeBlanc(9), Mark Loeb(9), Donna MacKinnon‐Cameron(9), Allison McGeer(9), Shelly McNeil(9), Hanna Nohynek(9), John Paget(9), Terho Heikkinen(9), Guy Boivin(8), William Bowie(8), Kevin Katz(8)